A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.
about
Incretin physiology and pathophysiology from an Asian perspectivePost-load insulin resistance is an independent predictor of hepatic fibrosis in virus C chronic hepatitis and in non-alcoholic fatty liver diseaseDown-regulation of pyruvate dehydrogenase phosphatase in obese subjects is a defect that signals insulin resistanceExpansion of the homeostasis model assessment of β-cell function and insulin resistance to enable clinical trial outcome modeling through the interactive adjustment of physiology and treatment effects: iHOMA2Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes MellitusCirculating CD36 is reduced in HNF1A-MODY carriersPancreatic adipose tissue infiltration, parenchymal steatosis and beta cell function in humans.Effects of meal frequency on metabolic profiles and substrate partitioning in lean healthy males.Mechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.Effects of meal and incretins in the regulation of splanchnic blood flow.Estimation of beta-cell function from the data of the oral glucose tolerance test.Reduced basal ATP synthetic flux of skeletal muscle in patients with previous acromegalyRandomized controlled trial of the efficacy of aerobic exercise in reducing metabolic risk in healthy older people: The Hertfordshire Physical Activity Trial.Osteocalcin is related to enhanced insulin secretion in gestational diabetes mellitus.Discovery of biomarkers for glycaemic deterioration before and after the onset of type 2 diabetes: rationale and design of the epidemiological studies within the IMI DIRECT ConsortiumHypertension in obese type 2 diabetes patients is associated with increases in insulin resistance and IL-6 cytokine levels: potential targets for an efficient preventive interventionProgression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onsetMuscle fiber capillarization as determining factor on indices of insulin sensitivity in humans.Fatty liver index predicts further metabolic deteriorations in women with previous gestational diabetesCassia cinnamon does not change the insulin sensitivity or the liver enzymes in subjects with impaired glucose toleranceBiomarkers of endothelial dysfunction in relation to impaired carbohydrate metabolism following pregnancy with gestational diabetes mellitusβ-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes.Progression to type 2 diabetes in women with former gestational diabetes: time trajectories of metabolic parameters.Body and liver fat mass rather than muscle mitochondrial function determine glucose metabolism in women with a history of gestational diabetes mellitus.Association of insulin resistance indexes to carotid intima-media thickness.Extracts from Salvia-Nelumbinis naturalis alleviate hepatosteatosis via improving hepatic insulin sensitivity.The efficacy and safety of saxagliptin when added to metformin therapy in patients with inadequately controlled type 2 diabetes with metformin aloneSaxagliptin added to a submaximal dose of sulphonylurea improves glycaemic control compared with uptitration of sulphonylurea in patients with type 2 diabetes: a randomised controlled trialImproved metabolic control by Ipomoea batatas (Caiapo) is associated with increased adiponectin and decreased fibrinogen levels in type 2 diabetic subjects.The assessment of insulin resistance in man.Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms.Surrogate markers of insulin resistance: A review.Routine OGTT: a robust model including incretin effect for precise identification of insulin sensitivity and secretion in a single individualClinical characteristics of OGTT-derived hepatic- and muscle insulin resistance in healthy young men.Computational assessment of insulin secretion and insulin sensitivity from 2-h oral glucose tolerance tests for clinical use for type 2 diabetes.Pathophysiological characteristics and effects of obesity in women with early and late manifestation of gestational diabetes diagnosed by the International Association of Diabetes and Pregnancy Study Groups criteria.Hepatic rather than cardiac steatosis relates to glucose intolerance in women with prior gestational diabetesComparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance.Hidden metabolic disturbances in women with normal glucose tolerance five years after gestational diabetes.Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD)
P2860
Q26784623-BF6DE39B-A6EE-437B-96B5-30A32CDD725AQ27481042-ADDD4E83-A13F-4FB3-B3E0-8F8DB73AB149Q28251109-1941263C-E740-4F63-AB7C-CA3BCB4F058BQ28288604-9F905889-C8D9-4515-9C82-647A58C14CBCQ28395801-6D6B5E93-ACCA-47B7-AE3D-71CC20CDD9C3Q28533348-B7678F61-A888-459C-82D3-A10FE6F48F13Q30903914-E4856F80-3A95-4F66-B428-DE4080D4F3D3Q31066247-B95F589D-A14D-44D0-85FD-70559DF1635DQ31137356-60BF6EAC-5BE6-4BCE-BF95-D77FACB5D461Q31170579-916EA53D-A7BA-4C16-A55E-A6831615F5A0Q33272514-18E563E3-480D-4846-A6DF-8700ECCD2DDCQ33394238-E6B3880B-63D1-4105-A40C-9367DC61564EQ33471743-0261CCDE-06A3-4E45-BB35-59E1CA1610E5Q33556735-AB83FC3C-60D4-4435-8E5A-D58913C0E875Q33600199-F22433C1-3CD2-4416-8738-0AEAD2BDE0E6Q33627932-92F13626-162E-4F6A-AE45-95A3CD9031F7Q33688616-59F9E5BA-65F4-4E5E-A31C-5A9420820419Q33740906-82B2C15B-56DF-459A-AE29-B2E2A0B34FD0Q34185998-1456C9E7-1879-43FA-A799-6CFCBECF35A0Q34266920-43E2CC6A-A0F0-4F75-876D-4A9DA3018B83Q34340112-5BD57E5A-CF84-4EB3-9393-2E4D4693884AQ34393402-963593F1-D7C6-44B1-8BDA-B095DDCC66EFQ34491423-16556450-6F56-451F-A338-86A59B882693Q34507228-5C862AAC-5F28-4BE6-B1C5-F2A33D15D5C9Q34552004-BFA2433C-1D18-48B4-820F-7E80C3E8187EQ34571695-6215FDED-9C8B-4907-BC2C-E96CC759E163Q34608300-E6AE58B6-3D04-4BD5-8EA3-0CAB7E6FCDE5Q34610019-997F1587-4AB2-4C51-B8E7-A6C94DE6165EQ34655064-DD0BDD66-17FB-4746-A0A1-F543D93779EFQ34722579-DA52B289-9A1A-4F19-A2F6-2F88F88B6ACFQ34743192-1B87F0A5-B6DF-4F63-8183-E1830FD42F8FQ34877758-DA9A717D-14F8-47B2-994B-B661F580CA42Q34979449-24B57C9D-9C2B-438F-B05C-C4F669795681Q35064831-E03E84C4-2DD8-4CDB-8620-CDF4A52AE09BQ35074878-D65A1B3B-BB21-4BC7-99F8-EA72498AADDAQ35096880-79C6E043-459D-43A6-AE69-8A911B6D6472Q35118617-719AF77E-FC7C-4925-91D1-3B2D7F3590A7Q35147540-5D122C5D-1017-40E6-BD00-A3DA9D53B8E7Q35271525-DAF21386-ECAF-49B1-9274-7084AD1027D4Q35560934-AD0A6E8A-8908-43BB-8142-7AA1389F0391
P2860
A model-based method for assessing insulin sensitivity from the oral glucose tolerance test.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
A model-based method for asses ...... e oral glucose tolerance test.
@en
A model-based method for asses ...... e oral glucose tolerance test.
@nl
type
label
A model-based method for asses ...... e oral glucose tolerance test.
@en
A model-based method for asses ...... e oral glucose tolerance test.
@nl
prefLabel
A model-based method for asses ...... e oral glucose tolerance test.
@en
A model-based method for asses ...... e oral glucose tolerance test.
@nl
P2093
P356
P1433
P1476
A model-based method for asses ...... e oral glucose tolerance test.
@en
P2093
P304
P356
10.2337/DIACARE.24.3.539
P407
P577
2001-03-01T00:00:00Z